Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Amigo AI Raises $11M Series A to Train Clinical AI Agents Like Doctors
Platform Pioneering “Digital Residency” for Clinical AI Reaches 3M+ Autonomous Patient Encounters with 100% Safety Pass Rate
Amigo AI, the platform for building and training patient-facing clinical agents, today announced an $11M Series A led by Madrona with participation from Optum Ventures. The company has now raised $17M in total funding, including a seed round co-led by General Catalyst and GSV Ventures. The raise comes amid growing momentum for the application of AI in healthcare, fueled by regulatory shifts toward technology-enabled care delivery (e.g., CMS ACCESS model) and growing provider demand for clinical agents.
Amigo builds and trains AI agents that interact directly with patients across clinical use cases such as intake and triage, personalized care navigation, and 24/7 patient support. By handling high-value clinical workflows, Amigo agents enable healthcare organizations to improve patient outcomes and meaningfully expand the reach and impact of their existing care teams.
In just the last six months, Amigo agents have completed over three million patient encounters around the world with zero safety incidents. The company now powers clinical AI for leading healthcare organizations around the world, including Eucalyptus, Diverge Health, and The Care Clinic.
“Amigo is addressing one of the hardest problems in healthcare AI, deploying autonomous systems where trust and safety are non-negotiable,” said Sabrina Albert, Partner at Madrona. “Their simulation-first approach to clinical safety positions them to define the standard for patient-facing AI.”
By 2030, the world will face a shortage of 11 million health workers. Clinical agents offer a promising path to closing this gap, but only if they can deliver care as safely as human clinicians.
“We train our agents like doctors because mistakes can cost lives in healthcare,” said Ali Khokhar, Founder and CEO at Amigo…
Full release here, originally announced March 10th, 2026.
$150M Investment Validates Grow Therapy as the Trusted Choice for Health Insurers, Employers, and Health Systems
With $150 Million in New Funding, Grow Therapy is Expanding its Platform to Connect Insurers, Employers, and Health Systems to Integrated Mental Health Care
At Grow Therapy, we recognized a hard truth: when Americans need mental health care most, the system too often fails them.
It asks people to navigate a maze of disconnected providers, insurance gaps, and long waitlists. So we set out to clear the pathway to effective care by breaking down those barriers.
Today, I’m excited to share a meaningful milestone in that journey.
Grow Therapy has raised a $150 million Series D, led by TCV and Growth Equity at Goldman Sachs Alternatives, who led our Series B and C, respectively. New investors BCI and Menlo Ventures join existing investors Sequoia, SignalFire, and Transformation Capital.
This round is the direct result of what we’re seeing every day: health plans, employers, and health systems are choosing Grow as a partner to deliver high-quality, affordable mental healthcare to people who need it.
“TCV loves backing great entrepreneurs targeting very large market opportunities. We are excited to continue to partner with Grow on the journey to provide access to, and improvement of, quality mental health care,” said Jay Hoag, Founding General Partner at TCV.
Our Progress
In just five years, over two million people have turned to Grow for mental health care. In 2025 alone, we facilitated seven million visits, bringing the lifetime total to 10 million therapy and medication management appointments…
Full release here, originally announced March 3rd, 2026.
No comments:
Post a Comment